Antibody-drug conjugate T-DM1 treatment for HER2+ breast cancer induces ROR1 and confers resistance through activation of Hippo transcriptional coactivator YAP1Research in context

by Syed S. Islam, Mohammed Uddin, Abu Shadat M. Noman, Hosneara Akter, Nusrat J. Dity, Mohammad Basiruzzman, Furkan Uddin, Jahanara Ahsan, Sunera Annoor, Ayodele A. Alaiya, Monther Al-Alwan, Herman Yeger, Walid A. Farhat
Published 2019-05-01